semaglutide deaths 2024 cuts risk for worsening heart failure, CV death among adults with HFpEF Study Shows 58% Of Patients

Twenty years ago, GLP-1 agonists were niche diabetes drugs

I often like to point out that patents were a cutting-edge social policy in the 18th century, and my view is that the strong US patent system enormously contributed to the great technological advances in the 19th and 20th centuries and continue today

[DOI] [PMC free article] [PubMed] [Google Scholar] 63.Patel F, Gan A, Chang K, Vega KJ

The choice of GLP-1 pill versus injection depends on comfort, lifestyle, and insurance coverage

When insulin is not working properly, glucose builds up in the blood, leading to high blood sugar levels

Yellowing of skin or eyes (jaundice) in severe cases